ArticleActa orthopaedica2013
Patient and implant survival following joint replacement because of metastatic bone disease.
Article in Acta orthopaedica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.
- Total HIP arthroplasty following pelvic irradiation: a systematic review focusing on the last two decades.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025Pooled it
- Longitudinal survival trends of patients with cancer with surgically managed appendicular metastatic bone disease: systematic review.Canadian journal of surgery. Journal canadien de chirurgiePooled it
- Epidemiology and Treatment of Metastatic Lesions Around the Elbow: A Systematic Review.Journal of clinical medicine · 2025Review
- Surgical management of metastatic lesions in the proximal femur: a systematic review.EFORT open reviews · 2025Article
- Does Perioperative Radiation Affect Implant Survivorship of Primary Total Hip Arthroplasty in the Setting of Metastatic Bone Disease?Arthroplasty today · 2024Article
- Risk Factors for Early Postoperative Morbidity and Mortality following Extremity Metastatic Pathologic or Impending Fracture Fixation.International journal of surgical oncology · 2024Article
- The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis.Journal of bone oncology · 2023Article
- Major surgery for metastatic bone disease is not a risk for 30-day mortality: a population-based study from Denmark.Acta orthopaedica · 2023Article
- Is a single dose of preoperative antibiotic therapy effective for patients treated with megaendoprosthesis after metastatic bone tumour resection?Musculoskeletal surgery · 2022Article
- Surgical Treatment of Metastatic Bone Disease in the Appendicular Skeleton: A Population-Based Study.Cancers · 2022Article
- Case report: A balance of survival and quality of life in long-term survival case of lung adenocarcinoma with synchronous bone metastasis.Frontiers in oncology · 2022Article
- Joint replacement surgery for elbow tumours: a systematic review of outcomes.Shoulder & elbow · 2021Review
- Quantitative measurements of adaptive bone remodeling around the cemented Zimmer® segmental stem after tumor resection arthroplasty using dual-energy x-ray absorptiometry.BMC musculoskeletal disorders · 2021Article
- Patient-reported assessment of outcome after surgery for bone metastases.Orthopedic reviews · 2021Article
- Impact of comorbidity on the short- and medium-term risk of revision in total hip and knee arthroplasty.BMC musculoskeletal disorders · 2020Article
- A novel scoring system to guide prognosis in patients with pathological fractures.Journal of orthopaedic surgery and research · 2018Article
- Percutaneous Palliative Surgery for Femoral Neck Metastasis Using Hollow Perforated Screw Fixation and Bone Cement.JB & JS open access · 2017Article
- Outcome of Skeletal Reconstructive Surgery for Metastatic Bone Tumours in the Femur.Malaysian orthopaedic journal · 2017Article
- Observational
- Low infection rate after tumor hip arthroplasty for metastatic bone disease in a cohort treated with extended antibiotic prophylaxis.Advances in orthopedics · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients suffering from a pathological fracture or painful bony lesion because of metastatic bone disease often benefit from a total joint replacement. However, these are large operations in patients who are often weak. We examined the patient survival and complication rates after total joint replacement as the treatment for bone metastasis or hematological diseases of the extremities. PATIENTS AND
methods130 patients (mean age 64 (30-85) years, 76 females) received 140 joint replacements due to skeletal metastases (n = 114) or hematological disease (n = 16) during the period 2003-2008. 21 replaced joints were located in the upper extremities and 119 in the lower extremities. Clinical and survival data were extracted from patient files and various registers.
resultsThe probability of patient survival was 51% (95% CI: 42-59) after 6 months, 39% (CI: 31-48) after 12 months, and 29% (CI: 21-37) after 24 months. The following surgical complications were seen (8 of which led to additional surgery): 2-5 hip dislocations (n = 8), deep infection (n = 3), peroneal palsy (n = 2), a shoulder prosthesis penetrating the skin (n = 1), and disassembly of an elbow prosthesis (n = 1). The probability of avoiding all kinds of surgery related to the implanted prosthesis was 94% (CI: 89-99) after 1 year and 92% (CI: 85-98) after 2 years.
conclusionJoint replacement operations because of metastatic bone disease do not appear to have given a poorer rate of patient survival than other types of surgical treatment, and the reoperation rate was low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.